Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCR | MLTX | DNLI | ||
| Company | Novocure Ltd Ord Sh | Moonlake Immunotherapeutics | Denali Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.33 | 51.71 | 21.36 | ||
| High | 31.52 | 54.10 | 22.21 | ||
| Low | 30.33 | 50.21 | 21.00 | ||
| Last | 30.80 | 52.17 | 21.45 | ||
| Change | +0.40 | +0.29 | -0.04 | ||
| % Change | +1.32% | +0.56% | -0.19% | ||
| Volume | 1,820,700 | 192,700 | 2,810,600 | ||
| 20-Day Average Volume | 1,948,210 | 190,135 | 965,450 | ||
| Previous Close | 30.40 | 51.88 | 21.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.39 | 53.42 | 23.81 | ||
| 20-Day Raw Stochastic | 80.45% | 24.35% | 12.73% | ||
| 20-Day Relative Strength | 64.80% | 50.45% | 35.36% | ||
| Weighted Alpha | +93.99 | -4.47 | -9.00 | ||
| Today's Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Last Month's Opinion | 24% Sell | 72% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.81% since 12/13/24 | +1.62% since 12/13/24 | -6.62% since 12/13/24 | ||
| Low | 29.79 on 12/19/24 | 50.21 on 12/20/24 | 20.76 on 12/19/24 | ||
| High | 34.13 on 12/18/24 | 58.26 on 12/17/24 | 24.15 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +82.68% since 11/20/24 | +4.72% since 11/20/24 | -12.16% since 11/20/24 | ||
| Low | 16.30 on 11/21/24 | 48.91 on 11/21/24 | 20.76 on 12/19/24 | ||
| High | 34.13 on 12/18/24 | 58.26 on 12/17/24 | 26.18 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | +76.50% since 09/20/24 | -3.46% since 09/20/24 | -30.60% since 09/20/24 | ||
| Low | 14.17 on 10/08/24 | 45.24 on 10/31/24 | 20.76 on 12/19/24 | ||
| High | 34.13 on 12/18/24 | 58.26 on 12/17/24 | 33.33 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +60.63% since 06/20/24 | +32.11% since 06/20/24 | +0.23% since 06/20/24 | ||
| Low | 14.17 on 10/08/24 | 37.55 on 06/24/24 | 19.74 on 08/05/24 | ||
| High | 34.13 on 12/18/24 | 58.26 on 12/17/24 | 33.33 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,332,590 | 3,333,923 | 3,087,127 | ||
| Shares Outstanding, K | 108,201 | 63,905 | 143,922 | ||
| Annual Sales | 509,340,000 | 0 | 330,530,000 | ||
| Annual Net Income | -207,040,000 | -36,010,000 | -145,220,000 | ||
| Last Quarter Sales | 155,100,000 | 0 | 0 | ||
| Last Quarter Net Income | -30,570,000 | -35,390,000 | -107,190,000 | ||
| 60-Month Beta | 0.75 | 1.31 | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 10/30/24 | -0.56 on 11/07/24 | -0.63 on 11/06/24 | ||
| Latest Earnings Date | 10/30/24 | 11/12/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||